BL
Benjamin Landry
General Counsel

Benjamin Landry insider trades: Health Catalyst (HCAT) stock sales

General Counsel, Health Catalyst Last trade Dec 5, 2025 28 Form 4 filings
$72K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2023
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Benjamin reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 5, 2025HCAT↓ Sell$72K
Sep 5, 2025HCAT↓ Sell$21K
Jun 5, 2025HCAT↓ Sell$24K
Mar 6, 2025HCAT↓ Sell$63K
Jan 6, 2025HCAT↓ Sell$19K
Dec 6, 2024HCAT↓ Sell$160K
Sep 6, 2024HCAT↓ Sell$18K
Jun 6, 2024HCAT↓ Sell$16K
May 31, 2024HCAT↓ Sell$83K
Sep 6, 2023HCAT↓ Sell$13K
Jul 7, 2023HCAT↓ Sell$13K
Jun 6, 2023HCAT↓ Sell$13K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other HCAT insiders

Open-market trades in the last 12 months

About Benjamin Landry's insider trades

Benjamin Landry is General Counsel at Health Catalyst (HCAT). Since Jun 6, 2023, Benjamin has reported no open-market purchases and 12 sales worth $515K on SEC Form 4. In the last 12 months: 1 sale ($72K).

Their filings also include shares withheld for taxes (14 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HCAT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.